Congress trades

DENTSPLY SIRONA Inc. (XRAY)

NASDAQ · Healthcare · 36 congress trades · last filed 2 years ago

20
Congress disclosures shown
36d
Median delay on the congress disclosures
of the 45 day limit
10 buys·10 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades XRAY.

Free on iOS and Android.

About DENTSPLY SIRONA Inc.

from the company's filings and listing, as of Oct 24, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
Daniel T. Scavilla
Employees
14,000
Listed since
Aug 12, 1987
Market value
$1.9B
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$2.73
Dividend yield
3.39%

www.dentsplysirona.com

Earnings

6 reported quarters · next on Nov 5, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026$0.52$0.35$898.0M$889.9MEPS beatRevenue in line
Q1 FY2026reported May 5, 2026$0.27$0.28$880.0M$841.8MEPS missRevenue beat
Q4 FY2025reported Feb 26, 2026$0.27$0.28$961.0M$926.2MEPS missRevenue beat
Q3 FY2025reported Nov 6, 2025$0.37$0.45$904.0M$927.1MEPS missRevenue miss
Q2 FY2025reported Aug 7, 2025$0.52$0.50$936.0M$904.6MEPS beatRevenue beat
Q1 FY2025reported May 8, 2025$0.43$0.29$879.0M$920.2MEPS beatRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Apr 23, 2026
ExecutiveSalaryStock awardsOtherTotal
Daniel T. ScavillaPresident and Chief Executive Officer$432K$3.5M$4.8M$8.8M
Robert (Tony) A. JohnsonSenior Vice President, Chief Supply Chain Officer$572K$1.4M$3.7M$5.7M
Andrea L. FrohningSenior Vice President, Chief Human Resources Officer$481K$810K$1.1M$2.4M
Aldo M. DentiExecutive Vice President, Chief Commercial Officer$188K$0$1.3M$1.5M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 3 executives who have since left the company are named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$283.4M26,711,079+38.7%13.38%
Fuller & Thaler Asset Management, Inc.$134.7M12,697,269-0.7%6.36%
Vanguard Portfolio Management LLC$125.0M11,779,851+11.9%5.90%
AQR Capital Management LLCCliff Asness$110.2M10,458,771+163.8%5.24%
State Street Corp$98.5M9,285,298+28.2%4.64%
Vanguard Capital Management LLC$96.0M9,047,628+0.5%4.53%
Lazard Asset Management LLC$87.7M8,269,867+23.1%4.14%
Ariel Investments, LLC$85.2M8,026,107+25.7%4.02%
Southpoint Capital Advisors LP$74.3M7,000,000-30.0%3.51%
Cooke & Bieler LP$73.5M6,927,915-11.2%3.47%
Geode Capital Management, LLC$60.0M5,650,605+47.8%2.83%
Invenomic Capital Management LP$52.1M4,909,808+11.8%2.46%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next XRAY filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in XRAY

20 disclosures of 36 on record · median 36d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-49.3%After the saleS&P 500 +29.0% · -78.4 pts vs S&P 500Jan 7, 2025Feb 11, 202535d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-50.0%After the saleS&P 500 +28.9% · -78.8 pts vs S&P 500Jan 8, 2025Feb 11, 202534d
Ro KhannaStockSale$1,001 - $15,000-67.7%After the saleS&P 500 +74.9% · -142.6 pts vs S&P 500Nov 3, 2023Dec 6, 202333d
Ro KhannaStockPurchase$1,001 - $15,000-72.1%S&P 500 +77.9% · -150.0 pts vs S&P 500Oct 2, 2023Nov 8, 202337d
Ro KhannaStockPurchase$1,001 - $15,000-76.2%S&P 500 +83.3% · -159.5 pts vs S&P 500May 2, 2022Jun 10, 202239d
Michael T. McCaulStockSale$15,001 - $50,000-77.6%After the saleS&P 500 +70.8% · -148.4 pts vs S&P 500Apr 19, 2022May 25, 202236d
Ro KhannaStockSale$1,001 - $15,000-80.5%After the saleS&P 500 +72.7% · -153.3 pts vs S&P 500Apr 11, 2022May 6, 202225d
Michael T. McCaulStockPurchase$1,001 - $15,000-82.4%S&P 500 +66.2% · -148.6 pts vs S&P 500Feb 2, 2022Mar 17, 202243d
Michael T. McCaulStockPurchase$1,001 - $15,000-83.3%S&P 500 +70.3% · -153.7 pts vs S&P 500Feb 15, 2022Mar 17, 202230d
Michael T. McCaulStockPurchase$1,001 - $15,000-83.3%S&P 500 +70.1% · -153.5 pts vs S&P 500Feb 16, 2022Mar 17, 202229d
Michael T. McCaulStockSale$1,001 - $15,000-82.3%After the saleS&P 500 +72.0% · -154.3 pts vs S&P 500Jan 28, 2022Feb 23, 202226d
Lois FrankelStockSale$1,001 - $15,000-81.4%After the saleS&P 500 +67.6% · -149.0 pts vs S&P 500Dec 3, 2021Jan 16, 202244d
Lois FrankelStockSale$1,001 - $15,000-81.7%After the saleS&P 500 +65.6% · -147.3 pts vs S&P 500Dec 5, 2021Jan 16, 202242d
Ro KhannaStockPurchase$1,001 - $15,000-83.1%S&P 500 +62.2% · -145.3 pts vs S&P 500Nov 5, 2021Dec 7, 202132d
Michael T. McCaulStockSale$1,001 - $15,000-85.3%After the saleS&P 500 +76.5% · -161.8 pts vs S&P 500Jul 1, 2021Aug 18, 202148d
Michael T. McCaulStockSale$15,001 - $50,000-85.3%After the saleS&P 500 +76.5% · -161.8 pts vs S&P 500Jul 1, 2021Aug 18, 202148d
Michael T. McCaulStockPurchase$1,001 - $15,000-82.6%S&P 500 +107.3% · -189.9 pts vs S&P 500Dec 10, 2020Jan 25, 202146d
Ro KhannaStockPurchase$1,001 - $15,000-77.9%S&P 500 +134.7% · -212.6 pts vs S&P 500Sep 23, 2020Oct 21, 202028d
Michael T. McCaulStockPurchase$1,001 - $15,000-75.0%S&P 500 +165.6% · -240.6 pts vs S&P 500May 15, 2020Jun 15, 202031d
Michael T. McCaulStockPurchase$50,001 - $100,000-74.8%S&P 500 +201.8% · -276.7 pts vs S&P 500Apr 2, 2020May 18, 202046d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in XRAY, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded XRAY?

Gilbert Ray Cisneros, Jr., Ro Khanna, Michael T. McCaul and Lois Frankel disclosed XRAY transactions in the filings shown here.

How quickly are XRAY trades disclosed?

Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track